Koo, I think having Dicky To on the BOD is an advantage. ORI put up their money, got a seat on the board and converted debt to shares. Since it is ORI "Capital" I assume their goal is ROI, so, I feel, just an opinion, they won't sit around while Don does nothing and we haven't seen any evidence that the business side has achieved anything since the failure of BoM almost 2 years ago. Yet ORI is in and they are insiders with privilaged knowledge. Hence, my vote of confidence. It can't hurt to have bright minds on the BOD.

If ORI achieves it's objectives I believe we will all benefit.

I have no idea what Hepa's goals are but it sure would be a major victory for a Chinese pharma to own all of this leading edge IP. Just foolish speculation on my part.

I do hope we will hear something soon at both RVX and ZCC. Now I'll try to shut up because I know I'm not helping matters.

GLTA

Toinv